218 related articles for article (PubMed ID: 24379197)
1. In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae.
Piccinelli G; Fernandes P; Bonfanti C; Caccuri F; Caruso A; De Francesco MA
Antimicrob Agents Chemother; 2014; 58(3):1693-8. PubMed ID: 24379197
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin.
Yao W; Xu G; Li D; Bai B; Wang H; Cheng H; Zheng J; Sun X; Lin Z; Deng Q; Yu Z
BMC Infect Dis; 2019 Feb; 19(1):175. PubMed ID: 30782125
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of strains of Streptococcus agalactiae to macrolides and lincosamides, phenotype patterns and resistance genes.
Aracil B; Miñambres M; Oteo J; De La Rosa M; Gómez-Garcés JL; Alós AJ
Clin Microbiol Infect; 2002 Nov; 8(11):745-8. PubMed ID: 12445014
[TBL] [Abstract][Full Text] [Related]
4. Macrolide- and tetracycline-resistance determinants of colonizing group B streptococcus in women in Egypt.
Shabayek S; Abdalla S
J Med Microbiol; 2014 Oct; 63(Pt 10):1324-1327. PubMed ID: 25053798
[TBL] [Abstract][Full Text] [Related]
5. Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy.
De Francesco MA; Caracciolo S; Gargiulo F; Manca N
Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1741-7. PubMed ID: 22120421
[TBL] [Abstract][Full Text] [Related]
6. Results from the Solithromycin International Surveillance Program (2014).
Farrell DJ; Flamm RK; Sader HS; Jones RN
Antimicrob Agents Chemother; 2016 Jun; 60(6):3662-8. PubMed ID: 27044551
[TBL] [Abstract][Full Text] [Related]
7. Macrolide and tetracycline resistance in clinical strains of Streptococcus agalactiae isolated in Tunisia.
Hraoui M; Boutiba-Ben Boubaker I; Rachdi M; Slim A; Ben Redjeb S
J Med Microbiol; 2012 Aug; 61(Pt 8):1109-1113. PubMed ID: 22538994
[TBL] [Abstract][Full Text] [Related]
8. Genetic characterization and diversity of Streptococcus agalactiae isolates with macrolide resistance.
Brzychczy-Włoch M; Gosiewski T; Bodaszewska M; Pabian W; Bulanda M; Kochan P; Strus M; Heczko PB
J Med Microbiol; 2010 Jul; 59(Pt 7):780-786. PubMed ID: 20339021
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
McGhee P; Clark C; Kosowska-Shick KM; Nagai K; Dewasse B; Beachel L; Appelbaum PC
Antimicrob Agents Chemother; 2010 Jan; 54(1):230-8. PubMed ID: 19884376
[TBL] [Abstract][Full Text] [Related]
10. Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates.
Figueira-Coelho J; Ramirez M; Salgado MJ; Melo-Cristino J
Microb Drug Resist; 2004; 10(1):31-6. PubMed ID: 15140391
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and Genotypic Characterization of Resistance to Macrolides and Lincosamides in
Novosak M; Bobadilla F; Delgado O; Vergara M; Laczeski M
Microb Drug Resist; 2020 Dec; 26(12):1472-1481. PubMed ID: 32315569
[TBL] [Abstract][Full Text] [Related]
12. High rates of macrolide resistance among clinical isolates of Streptococcus agalactiae in Tunisia.
Rachdi M; Boutiba-ben Boubaker I; Hraoui M; Ben Redjeb S
Arch Inst Pasteur Tunis; 2010; 87(1-2):35-42. PubMed ID: 21598827
[TBL] [Abstract][Full Text] [Related]
13. [Serotypes and antimicrobial susceptibility of Streptococcus agalactiae].
Martínez MA; Ovalle A; Durán C; Reid I; Urriola G; Garay B; Cifuentes M
Rev Med Chil; 2004 May; 132(5):549-55. PubMed ID: 15279140
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.
Bemer-Melchior P; Juvin ME; Tassin S; Bryskier A; Schito GC; Drugeon HB
Antimicrob Agents Chemother; 2000 Nov; 44(11):2999-3002. PubMed ID: 11036012
[TBL] [Abstract][Full Text] [Related]
15. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.
Uh Y; Shin DH; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924
[TBL] [Abstract][Full Text] [Related]
17. [Susceptibility patterns and mechanisms of macrolide resistance in group B streptococcus isolates].
Shen AD; Zhang GR; Wang YH; Yang YH
Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):661-4. PubMed ID: 16191298
[TBL] [Abstract][Full Text] [Related]
18. [Serotype distribution and antibiotic susceptibilities of Streptococcus pneumoniae causing acute exacerbations and pneumonia in children with chronic respiratory diseases].
Altınkanat Gelmez G; Soysal A; Kuzdan C; Karadağ B; Hasdemir U; Bakır M; Söyletir G
Mikrobiyol Bul; 2013 Oct; 47(4):684-92. PubMed ID: 24237437
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance.
Betriu C; Culebras E; Rodríguez-Avial I; Gómez M; Sánchez BA; Picazo JJ
Antimicrob Agents Chemother; 2004 Jan; 48(1):323-5. PubMed ID: 14693558
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance profiles and genetic characterisation of macrolide resistant isolates of Streptococcus agalactiae.
Nakamura PA; Schuab RB; Neves FP; Pereira CF; Paula GR; Barros RR
Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):119-22. PubMed ID: 21537668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
